Conference Program

International Baltic Conference on Healthy Longevity 2025 Program

September 16
09:00 – 09:30 – Gathering & Registration
9:30-10:00 – Greetings by dignitaries

Professor Dr. Sc. Eng. Agris Ņikitenko. Dean. Riga Technical University 

Mr. Svens Henkuzens – Deputy State Secretary for Health Policy Affairs, Ministry of Health of the Republic of Latvia

Mr. Lauris Vidzis. CEO. Pauls Stradiņš Clinical University Hospital

Governance and Policies to Promote Healthy Longevity Research, Development and Application
10:00 – 10:20 – Dr. Ilia Stambler – Vetek (Seniority) Association – the Movement for Longevity and Quality of Life, Israel

Enhancing research, development, education and policy for healthy longevity – in the Baltics and globally

10:20 – 10:40 – Dr. Wouter De Tavernier – Health Policy Department. OECD – OCDE, France

Developing the OECD framework for healthy ageing

10:40-11:00 – Didier Coeurnelle – Healthy Life Extension Society (HEALES), Belgium

European Health Data Spaces (EHDS) and the sharing of health data for longevity

11:00 – 11:20 – Break

Enhancing Public Health and Preventive Healthcare for Healthy Longevity
11:20 – 11:40 – Dr. Svjatoslavs Kistkins – Pauls Stradiņš Clinical University Hospital, Latvia

Health literacy – the first intervention for healthy aging of the population

11:40 – 12:00 – Prof. Dr. Pedro Barata – Portuguese Society for Longevity Science and Medicine, Portugal

Optimization of longevity therapeutics and development of new medical devices and pharmaceutical dosage systems

12:00 – 12:20 – Dr. Elizabete Argale – Riga Stradins University

Extending healthy reproductive longevity

12:20 – 12:40 – Yuri Ostrinski – Institute of Microbiology and Virology, Riga Stradins University, Latvia

Physical exercise as a targeted healthy longevity intervention

12:40-13:00 – Prof. Arnon Afek – Sheba Medical Center, Israel

The national program for preventing cardiovascular diseases and diabetes

13:00 – 14:00 – Lunch Break
14:00 – 14:30 – Panel Discussion – Education for Healthy Longevity – from Scientists and Health Care Professionals to the General Public

Amit Goldman, EMBA, Longevity Education Hub; Dr. Svjatoslavs Kistkins, Pauls Stradiņš Clinical University Hospital; Dr. Silvija Valdonė Alšauskė, Lithuanian University of Health Sciences;  Dr.  Lika Levskaya, Longevity Alliance Baltic; Dr. Tamara Pheiffer, Afrolongevity, South Africa

Healthy Longevity Medicine – State of the Art and Vision of the Future. What Treatments can be Offered to Extend Healthspan Now and in the Near Future?
14:30 – 14:50 – Prof. Evelyne Bischof – Sheba Longevity Department at Sheba Medical Center, Israel

Pioneering Longevity Medicine: AI, Clinical Implementation & the Future

14:50 – 15:10 – Prof. Dr. MD. Bernd Kleine-Gunk – The German Society of Preventative and Anti-Aging Medicine (GSAAM), Germany

Hormone replacement therapy in postmenopausal women – is it a Longevity treatment?

15:10 – 15:40 – Panel Discussion – The Baltic Region – An Emerging Hub in the Global Longevity Ecosystem

Moderator: Dr. Rolands Lappuķe. Participants: Prof. Dr. Valdis Pirags, University of Latvia; Dr. Jānis Ancāns, Latvian Council of Science; Yuri Ostrinski, Riga Stradins University; Dr. Uģis Klētnieks, Longevity Alliance Baltic (LAB)

15:40 – 15:50 – Remarks and conclusions

September 17
09:00 – 10:00 – Gathering & Registration

Healthy Longevity Science – Advances of Geroscience. From Fundamental Studies to Clinical Trials and Application – New Models
10:00 – 10:20 – Prof. Morten Scheibye-Knudsen – University of Copenhagen, Denmark

Data-driven interventions in aging

10:20 – 10:40 – Prof. Dr. Valdis Pirags – University of Latvia, Pauls Stradiņš Clinical University Hospital, Latvia

New physiological models of longevity:  the role of metformin in countering hallmarks of aging

10:40-11:00 – Emil Syundyukov – Longenesis, Latvia

Digital technologies for population engagement in longevity research

11:00 – 11:20 – Break

Healthy Longevity Science – Advances of Geroscience. From Fundamental Studies to Clinical Trials and Application – New Interventions
11:20 -11:40 – Prof. Dr. Marek Postula, MD, PhD – Polish Society of Longevity Medicine, Poland

SGLT2 Inhibitors and GLP-1 Agonists – Modern Gerotherapeutics: A United Strategy or Separate Pathways?

11:40 – 12:00 – Dr. Ugis Kletnieks – Longevity Alliance Baltic, Latvia

The Role of Retrotransposable Elements (Retrobiome) in Aging and Age-Related Diseases

12:00 – 12:20 – Dr. Jesper Eugen-Olsen – Department of Cardiology, Copenhagen University Hospital Herlev and Gentofte, Denmark

Chronic Inflammation as the Hallmark of Aging: Association Between Elevated suPAR Biomarker and Accelerated Aging

12:20 – 12:40 – Dr. Scott Parkinson – Aqabela.EU SIA, Latvia

Microbiome: A pharmaceutical approach to longevity and disease prevention

12:40 – 13:00 – Prof. Odon Planinsek – L-Blend, Latvia; University of Ljubljana

Wine polyphenols – a multipotential geroprotective treatment

13:00 – 14:00 – Lunch Break

Healthy Longevity – International Perspectives
14:00 – 14:20 – Prof. Richard Barker – King’s College London, UK

Regulatory pathways for emerging longevity therapies

14:20 – 14:40 – Prof. Zenfira Gadimova – Institute of Physiology of Azerbaijan NAS, Dr. Gulshan Taghiyeva, Prof. Naila Ahmadova – Gerontological Centre of Baku, Azerbaijan

The vulnerability of the bioelectrical activity of the heart in older patients to the impact of COVID-19

14:40 – 15:00 – Needa Qureshi – Institute for Healthier Living Abu Dhabi, UAE

Mapping Interest in Healthy Longevity in the UAE: Demographics, Behavior & Literacy

15:00 – 15:10 – Dr. Tetiana Haiduk – Medical Center of the Charitable Foundation “Superhumans”, Dr. Larysa Tereshchenko – Dnepropetrovsk regional hospital for war veterans, Dnipro, Ukraine

The treatment of combat trauma in Ukraine – the struggle for healthy longevity under adverse conditions

15:10 – 15:30 – Sebastian A. Brunemeier – Long Game Ventures, US

Longevity Biotech (LongBio): A revolution in medicine — venture capital perspective

15:30 – 15:50 – Concluding remarks